GLP-1 S – 10mg

Description

GLP-1 S Peptide (Single-Pathway Agonist)

Batch Specific COA Download | COA Results Pending

GLP-1 S Peptide is a high-affinity, long-acting analog of the endogenous GLP-1 hormone, serving as a foundational pillar in metabolic research. Specifically, it targets the Glucagon-Like Peptide-1 receptor, mimicking the natural incretin effect with significantly enhanced stability. Therefore, it provides a sustained physiological signal compared to native peptides, which are rapidly degraded by DPP-4 enzymes. We offer this ultra-pure vial for investigators focused on the precise modulation of insulin secretion and appetite-regulating neural circuits. Currently, it is the primary tool for simulating “postprandial signaling” in laboratory models. So, labs use it to establish a baseline for incretin-based weight and glucose studies. Thus, it remains the gold standard for isolated GLP-1 receptor signaling.

How It Works

This peptide works like a “precision throttle” for the metabolism. First, it activates the GLP-1 receptors in the pancreas to stimulate glucose-dependent insulin secretion while simultaneously suppressing glucagon. This means the research subject experiences a tightly regulated glucose environment. Then, it engages the “gastric brake”: it significantly slows gastric emptying and signals the brain’s satiety centers. Unlike broader agonists, this targeted signal focuses on reducing caloric intake and optimizing glycemic control. Consequently, the research model doesn’t just show improved blood sugar levels; it shows a profound shift in energy balance. As a result, the body moves from “constant hunger” to “sustained satiety.” Furthermore, this single-action approach allows researchers to study the specific impact of GLP-1 without the interference of GIP or Glucagon receptor cross-talk.

Lab Uses

Frequently, labs use GLP-1 S Peptide for “Glycemic Control” modeling and obesity research. This helps measure the cumulative effect of delayed gastric emptying on nutrient absorption. Next, researchers investigate neuro-protective properties, specifically utilizing the GLP-1 pathway to study its effects on cognitive decline and neuro-inflammation in specialized models. Moreover, it pairs perfectly with tissue-repair sequences. Labs often stack it with BPC-157.

Synergistic Pairing: BPC-157 for Gastrointestinal Equilibrium

Ideally, this creates a “Systemic Stability” study. While GLP-1 S aggressively modulates metabolic signaling and slows digestion, the BPC-157 provides the cytoprotective support often needed to maintain gastrointestinal mucosal integrity. Finally, this ensures the research model can sustain long-term GLP-1 signaling without localized digestive distress.

Technical Specs

We ship this as a specialized lyophilized powder to ensure maximum peptide stability during transit.

Name: GLP-1 S Peptide
Scientific Alias: Semaglutide
Receptor Targets: GLP-1R (Selective Agonist)
Purity: ≥99% (HPLC Verified)
Format: Lyophilized Powder
Storage: Freeze at -20°C for long-term stability.

Reference Data

Pubmed: Glucagon-like peptide-1 receptor agonists in the treatment of type 2 diabetes and obesity

Research Use Only Warning

We sell this strictly for lab research. No Human Use: Do not use this GLP-1 S Peptide as a weight loss drug or medication. No Injections: It is not for personal medical use or human administration. Expert Use: Only trained staff and qualified investigators should handle this compound.